{"drugs":["Ascarel","Pamix","Pin-X","Pinworm","Pyrantel Pamoate"],"mono":{"0":{"id":"494950-s-0","title":"Generic Names","mono":"Pyrantel Pamoate"},"1":{"id":"494950-s-1","title":"Dosing and Indications","sub":[{"id":"494950-s-1-4","title":"Adult Dosing","mono":"<ul><li>doses given as base, dose forms as salt, 1 mg of pyrantel base equivalent to 2.88 mg of pyrantel pamoate salt<\/li><li><b>Ascariasis:<\/b> 11 mg\/kg base ORALLY once; MAX 1 g\/day<\/li><li><b>Enterobiasis:<\/b> 11 mg\/kg base ORALLY once as a single dose; MAX dose 1 g<\/li><li><b>Infection by Moniliformis:<\/b> 11 mg\/kg base ORALLY once; repeat twice, at 2-wk intervals<\/li><li><b>Infection by Uncinaria:<\/b> 11 mg\/kg base ORALLY daily for 3 days; MAX 1 g\/day<\/li><li><b>Trichostrongyliasis:<\/b> 11 mg\/kg base ORALLY once; MAX 1 g\/day<\/li><\/ul>"},{"id":"494950-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>doses given as base, dose forms as salt, 1 mg of pyrantel base equivalent to 2.88 mg of pyrantel pamoate salt<\/li><li><b>Ascariasis:<\/b> (2 yr and older): 11 mg\/kg base ORALLY once; MAX 1 g\/day<\/li><li><b>Enterobiasis:<\/b> (2 y and older) 11 mg\/kg base ORALLY once as a single dose; MAX dose 1 g<\/li><li><b>Infection by Moniliformis:<\/b> (2 yr and older): 11 mg\/kg base ORALLY once; repeat twice, at 2-wk intervals<\/li><li><b>Infection by Uncinaria:<\/b> (2 y and older) 11 mg\/kg base ORALLY daily for 3 days; MAX 1 g\/day<\/li><li><b>Trichostrongyliasis:<\/b> (2 yr and older): 11 mg\/kg base ORALLY once; MAX 1 g\/day<\/li><\/ul>"},{"id":"494950-s-1-6","title":"Dose Adjustments","mono":"liver disease"},{"id":"494950-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Enterobiasis<br\/><b>Non-FDA Labeled Indications<\/b><ul><li>Ascariasis<\/li><li>Infection by Moniliformis<\/li><li>Infection by Uncinaria<\/li><li>Trichostrongyliasis<\/li><\/ul>"}]},"3":{"id":"494950-s-3","title":"Contraindications\/Warnings","sub":[{"id":"494950-s-3-9","title":"Contraindications","mono":"hypersensitivity to pyrantel<br\/>"},{"id":"494950-s-3-10","title":"Precautions","mono":"<ul><li>liver disease<\/li><li>pregnancy<\/li><\/ul>"},{"id":"494950-s-3-11","title":"Pregnancy Category","mono":"<ul><li>Pyrantel: C (FDA)<\/li><li>Pyrantel: B2 (AUS)<\/li><\/ul>"},{"id":"494950-s-3-12","title":"Breast Feeding","mono":"<ul><li>Pyrantel: WHO: Compatible with breastfeeding.<\/li><li>Pyrantel: Micromedex: Infant risk cannot be ruled out.<\/li><\/ul>"}]},"5":{"id":"494950-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Diarrhea, Nausea, Vomiting<\/li><li><b>Neurologic:<\/b>Dizziness, Headache, Somnolence<\/li><\/ul>"},"6":{"id":"494950-s-6","title":"Drug Name Info","sub":{"0":{"id":"494950-s-6-17","title":"US Trade Names","mono":"<ul><li>Ascarel<\/li><li>Pamix<\/li><li>Pin-X<\/li><li>Pinworm<\/li><\/ul>"},"2":{"id":"494950-s-6-19","title":"Class","mono":"Anthelmintic<br\/>"},"3":{"id":"494950-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"494950-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"9":{"id":"494950-s-9","title":"Administration","mono":"<b>Oral<\/b><br\/><ul><li>take with or without food; may take with water, milk, or fruit juice<\/li><li>(suspension) shake well<\/li><\/ul>"},"10":{"id":"494950-s-10","title":"Monitoring","mono":"<ul><li>symptomatic improvement<\/li><li>perianal swab for ova or worms; stool culture<\/li><\/ul>"},"11":{"id":"494950-s-11","title":"How Supplied","mono":"<ul><li><b>Ascarel<\/b><br\/>Oral Suspension: 144 MG\/ML<br\/><\/li><li><b>Reese's Pinworm Medicine<\/b><br\/>Oral Suspension: 144 MG\/ML<br\/><\/li><\/ul>"},"12":{"id":"494950-s-12","title":"Toxicology","sub":[{"id":"494950-s-12-31","title":"Clinical Effects","mono":"<b>PYRANTEL<\/b><br\/>OVERDOSE: Overdose information is not available at the time of this review. ADVERSE EFFECTS: The most commonly reported adverse effects following therapeutic administration of pyrantel include headache, dizziness, drowsiness, insomnia, rashes, anorexia, nausea, vomiting, abdominal pain and diarrhea.  Transient elevations of serum transaminase levels have been reported in a small percentage of patients.<br\/>"},{"id":"494950-s-12-32","title":"Treatment","mono":"<b>PYRANTEL <\/b><br\/><ul><li>Support: Treatment is symptomatic and supportive.<\/li><li>Decontamination: Activated charcoal.<\/li><li>Monitoring of patient: Serum drug levels are not clinically useful. Monitor liver enzyme levels and fluid and serum electrolyte status in symptomatic patients.<\/li><\/ul>"},{"id":"494950-s-12-33","title":"Range of Toxicity","mono":"<b>PYRANTEL<\/b><br\/>TOXICITY: A toxic dose has not been established.  THERAPEUTIC: Adults and children 2 to 12 years of age - A single oral dose of 11 mg\/kg; maximum total dose 1 g.<br\/>"}]},"13":{"id":"494950-s-13","title":"Clinical Teaching","mono":"<ul><li>Patient should avoid activities requiring mental alertness or coordination until drug effects are realized, as drug may cause dizziness and somnolence.<\/li><li>This drug may cause gastrointestinal disturbance, nausea, vomiting, and headache.<\/li><\/ul>"}}}